Anúncio
Anúncio
IPHA
Innate Pharma S.A. ADS
1.79
USDPatrocinado
+0.05
+2.87%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
1.80
+0.01
+0.50%
Relatórios de Lucros IPHA
Rácio de surpresa positiva
IPHA separação 0 de 1 últimas estimativas.
%
Próximo Relatório
Data do Próximo Relatório
26 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$2.17M
/-$0.12
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/--
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/--
Innate Pharma S.A. ADS earnings per share and revenue
On 13 de nov. de 2025, IPHA reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.12 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 1.98 milhão, with a --% difference. The market reacted with a -5.21% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 2 analistas forecast an EPS of -0.12 USD, with revenue projected to reach 2.17 milhão USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Innate Pharma S.A. ADS's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Innate Pharma S.A. ADS reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Innate Pharma S.A. ADS's Q3 2025 earnings?
The stock price moved down -5.21%, changed from $1.92 before the earnings release to $1.82 the day after.
When is Innate Pharma S.A. ADS expected to report next?
The next earning report is scheduled for 26 de mar. de 2026.
What are the forecasts for Innate Pharma S.A. ADS's next earnings report?
Based on 2
analistas, Innate Pharma S.A. ADS is expected to report EPS of -$0.12 and revenue of $2.17M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio